4SCAR T for autoimmune diseases / SZGIMI - LARVOL DELTA

GIMI-IRB-24003: Autoimmune Disease Treatment With Mesenchymal Stem Cells (MSCs) and CAR-T Cells (clinicaltrials.gov) - P1/2 | N=30 | Not yet recruiting | Sponsor: Shenzhen Geno-Immune Medical Institute | Trial completion date: Dec 2027 ➔ Dec 2029 | Trial primary completion date: Jul 2027 ➔ Dec 2028

Trial completion date • Trial primary completion date • Immunology

CAR-T Cells Targeting Autoimmune Diseases (clinicaltrials.gov) - P1/2 | N=30 | Recruiting | Sponsor: Shenzhen Geno-Immune Medical Institute | Trial completion date: Jun 2026 ➔ Dec 2030 | Trial primary completion date: Jul 2025 ➔ Dec 2029

Trial completion date • Trial primary completion date • Immunology

GIMI-IRB-24003: Autoimmune Disease Treatment With Mesenchymal Stem Cells (MSCs) and CAR-T Cells (clinicaltrials.gov) - P1/2 | N=30 | Recruiting | Sponsor: Shenzhen Geno-Immune Medical Institute

CAR T-Cell Therapy • New P1/2 trial • Immunology